Stock MBRX MOLECULIN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-16 EDT 		5-day change 1st Jan Change
5.03 USD +2.24% Intraday chart for Moleculin Biotech, Inc. +5.23% -60.94%
05-15 Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (Nu 21C06) CI
05-13 Transcript : Moleculin Biotech, Inc., Q1 2024 Earnings Call, May 13, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MOLECULIN BIOTECH, INC. Stock Moleculin Biotech, Inc.
 11.2M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
ARGENX SE Stock argenx SE
 22.28B -
BIONTECH SE Stock BioNTech SE
 22.41B -
GENMAB A/S Stock Genmab A/S
 19.07B
  1. Stock Market
  2. Equities
  3. MBRX Stock
  4. Charts Moleculin Biotech, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW